Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Roberts

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Nutrition ESPEN|November 4, 2019
Nutritional management of cirrhosis patients: A qualitative study exploring perceptions of patients and health workers in GhanaYvonne Ayerki Nartey, Mawuena Asem, Adwoa Agyei-Nkansah, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 4, 2014
Cervical cancer screening in Ghana, west Africa: prevalence of abnormal cytology and challenges for expanding screeningKathryn S Handlogten, Rochelle J Molitor, Lindsey E Roeker, et al.
Research Square|December 4, 2023
Chimerization of the Anti-Viral CD8<sup>+</sup> T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapyRichard Vile, Mason Webb, Jacob van Vloten, et al.
Molecular Therapy Oncolytics|June 14, 2023
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic virusesMason J Webb, Timothy Kottke, Benjamin L Kendall, et al.
Cancer Research|June 29, 2012
Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironmentUsman Yaqoob, Sheng Cao, Uday Shergill, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Cancer Communications (London, England)|January 15, 2022
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentialsSung Hwan Lee, Yun Seong Jeong, Sunyoung Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
JCO Precision Oncology|November 15, 2021
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort ExperienceJennifer J Gile, Fang-Shu Ou, Amit Mahipal, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Nutrition ESPEN|November 4, 2019
Nutritional management of cirrhosis patients: A qualitative study exploring perceptions of patients and health workers in GhanaYvonne Ayerki Nartey, Mawuena Asem, Adwoa Agyei-Nkansah, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 4, 2014
Cervical cancer screening in Ghana, west Africa: prevalence of abnormal cytology and challenges for expanding screeningKathryn S Handlogten, Rochelle J Molitor, Lindsey E Roeker, et al.
Research Square|December 4, 2023
Chimerization of the Anti-Viral CD8<sup>+</sup> T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapyRichard Vile, Mason Webb, Jacob van Vloten, et al.
Molecular Therapy Oncolytics|June 14, 2023
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic virusesMason J Webb, Timothy Kottke, Benjamin L Kendall, et al.
Cancer Research|June 29, 2012
Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironmentUsman Yaqoob, Sheng Cao, Uday Shergill, et al.
Hepatology International|May 19, 2021
Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinomaChih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Cancer Communications (London, England)|January 15, 2022
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentialsSung Hwan Lee, Yun Seong Jeong, Sunyoung Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
JCO Precision Oncology|November 15, 2021
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort ExperienceJennifer J Gile, Fang-Shu Ou, Amit Mahipal, et al.
Pageof 4